Passion for Precision
ITM Radiopharma (itm-radiopharma.com) scores 73 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Manufacturing brands, in the 36th percentile of 20056 Healthcare brands.
ITM Radiopharma is a company operating in the radiopharmaceutical sector, focused on precision isotope manufacturing and targeted cancer therapies. It positions itself as a global leader in radiopharmaceutical innovation, aiming to improve cancer treatment outcomes for patients and physicians. The company serves cancer patients, oncologists, and healthcare systems by combining isotope production with therapeutic delivery to meet clinical expectations in oncology care.
| Brand Name | ITM Radiopharma |
|---|---|
| Domain | itm-radiopharma.com |
| Industry | Healthcare, Manufacturing |
| Main Competitors | Novartis (Advanced Accelerator Applications) (75/100), Curium Pharma (79/100), Lantheus Holdings (80/100), Telix Pharmaceuticals (75/100), Bayer (Radiopharmaceuticals) (76/100), POINT Biopharma (70/100), Fusion Pharmaceuticals (76/100) |
Moz Domain Authority 32/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #2,570,909 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "At ITM, precision drives everything - from isotope manufacturing to cancer treatment-improving outcomes and delivering what patients and physicians expect." (Meta description: 20 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 2 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, + Microdata, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Apache.
Social footprint: verified profiles on LinkedIn, YouTube, Instagram; no detected presence on X (Twitter), Facebook, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is ITM Radiopharma?", Claude could identify the brand as of October 2026. ITM Radiopharma is part of ITM Isotopen Technologien München, a German biotech company developing targeted radioligand therapies and diagnostics for cancer, particularly using isotopes like lutetium-177 and actinium-225. Best known for developing precision radiopharmaceuticals for targeted cancer therapy, including neuroendocrine tumor treatments.
When asked "Best brands similar to ITM Radiopharma?", Claude would recommend ITM Radiopharma as of October 2026. ITM is a recognized player in the growing radioligand therapy space, often mentioned alongside companies like Novartis (AAA) and Bayer in nuclear medicine oncology.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
ITM Radiopharma's main competitors in Healthcare: Novartis (Advanced Accelerator Applications) (75/100), Curium Pharma (79/100), Lantheus Holdings (80/100), Telix Pharmaceuticals (75/100), Bayer (Radiopharmaceuticals) (76/100).
Sources: Brand Analyzer scan
ITM Radiopharma has low AI-search visibility, scoring 21/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 34, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: ITM Radiopharma official site
ITM Radiopharma scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: ITM Radiopharma official site
ITM Radiopharma can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: ITM Radiopharma official site
ITM Radiopharma scores 21/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
ITM Radiopharma has a weak AI-visibility profile at 21/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (0/100). It benefits from a global traffic rank of #2,570,909 (Tranco), open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 32/100. In a live check, Claude could already identify ITM Radiopharma from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to ITM Radiopharma: International Society of Refractive Surgery (ISRS) (73/100), Irish Life Health (73/100), IUSTI (73/100), IVF Australia (73/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.